asa guidelines for glp 1 agonists Glucagon-Like Peptide-1 Receptor in Perioperative Care 🔸 Should GLP-1 RAs be

Early research is reassuring

emDOCs.net

Tirzepatide which targets both GLP-1 and GIP receptors has shown even more dramatic early results: weight loss of 1020 kg and insulin dose reductions exceeding 30% in observational and phase 2 data, with improved CGM time in range

Well, it turns out these creepy deep sea monsters have an entire organ for making glucagon, and it was just much easier to dissect that organ out than it was to painstakingly pluck the tiny number of glucagon making cells out of like a mouse's pancreas

In recent years, some of these drugs have also been approved to treat obesity and for weight loss

Mornigo R, Vidal J, Lacy AM, Delgado S, Casamitjana R, Gomis R